Potential role of HBGF (FGF) and TGF-beta on prostate growth
- PMID: 1492611
- DOI: 10.1007/978-1-4615-3398-6_11
Potential role of HBGF (FGF) and TGF-beta on prostate growth
Abstract
We review in this paper the role of heparin-binding growth factor (HBGF*) or fibroblast growth factor (FGF*), rat prostate cancer cells produce TGF-beta, IGF-II* and OGF*. Of these growth factors, TGF-beta and unknown labile factor with 19 kDa are the most probable candidates responsible for osteoblastic bony metastasis of prostate cancer. In vitro experiments suggest that TGF-beta modulates cell detachment of prostate cancer cells together with nutritional factors. HBGF-dependent growth of the prostate tumor epithelial cells is free from inhibition by TGF-beta, whereas normal prostate epithelial cells are sensitive to TGF-beta inhibition. Transfection experiments suggest that HBGF-2 (basic FGF) might be closely related to the malignant growth of prostate cancer, in addition to tumor angiogenesis.
Similar articles
-
Heparin-binding fibroblast growth factors and prostate cancer.Adv Exp Med Biol. 1993;330:203-13. doi: 10.1007/978-1-4615-2926-2_15. Adv Exp Med Biol. 1993. PMID: 7690178
-
Peptide growth factors in the prostate as mediators of stromal epithelial interaction.Br J Urol. 1996 May;77(5):627-33. doi: 10.1046/j.1464-410x.1996.09721.x. Br J Urol. 1996. PMID: 8689101 Review.
-
Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts.Prostate. 1993;22(3):183-97. doi: 10.1002/pros.2990220302. Prostate. 1993. PMID: 7683814
-
TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.Prostate. 1997 Apr 1;31(1):61-70. doi: 10.1002/(sici)1097-0045(19970401)31:1<61::aid-pros10>3.0.co;2-m. Prostate. 1997. PMID: 9108888 Review.
-
Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.Anticancer Res. 1997 May-Jun;17(3A):1461-5. Anticancer Res. 1997. PMID: 9179184 Review.
Cited by
-
Transforming growth factor-beta and prostate cancer.World J Urol. 1995;13(6):329-36. doi: 10.1007/BF00191213. World J Urol. 1995. PMID: 9116751 Review.
-
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.Cancer Gene Ther. 2006 Feb;13(2):115-24. doi: 10.1038/sj.cgt.7700896. Cancer Gene Ther. 2006. PMID: 16138117 Free PMC article. Review.
-
Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment.Urol Res. 1995;23(2):119-25. doi: 10.1007/BF00307942. Urol Res. 1995. PMID: 7676534
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical